Sefitude Húðuð tafla 445 mg 아이슬란드 - 아이슬란드어 - LYFJASTOFNUN (Icelandic Medicines Agency)

sefitude húðuð tafla 445 mg

florealis ehf. - valerian root dry extract (3-6:1), ethanol 70 %(v/v) - húðuð tafla - 445 mg

Qlaira Filmuhúðuð tafla 아이슬란드 - 아이슬란드어 - LYFJASTOFNUN (Icelandic Medicines Agency)

qlaira filmuhúðuð tafla

bayer ab - estradiolum valerat; dienogestum inn; estradiolum valerat - filmuhúðuð tafla

Betnovat Húðlausn 1 mg/ml 아이슬란드 - 아이슬란드어 - LYFJASTOFNUN (Icelandic Medicines Agency)

betnovat húðlausn 1 mg/ml

glaxosmithkline pharma a/s - betamethasonum valerat - húðlausn - 1 mg/ml

Ronapreve 유럽 연합 - 아이슬란드어 - EMA (European Medicines Agency)

ronapreve

roche registration gmbh  - casirivimab, imdevimab - covid-19 virus infection - Ónæmiskerfið sera og mótefni, - ronapreve is indicated for:treatment of covid-19 in adults and adolescents aged 12 years and older weighing at least 40 kg who do not require supplemental oxygen and who are at increased risk of progressing to severe covid-19 (see section 4. prevention of covid-19 in adults and adolescents aged 12 years and older weighing at least 40 kg (see section 4. the use of ronapreve should take into account information on the activity of ronapreve against viral variants of concern. sjá kafla 4. 4 og 5.

Pentocur (Tiopental Abcur) Stungulyfsstofn, lausn 1 g 아이슬란드 - 아이슬란드어 - LYFJASTOFNUN (Icelandic Medicines Agency)

pentocur (tiopental abcur) stungulyfsstofn, lausn 1 g

abcur ab - thiopentalum natricum inn - stungulyfsstofn, lausn - 1 g

Elocon Smyrsli 0,1 % 아이슬란드 - 아이슬란드어 - LYFJASTOFNUN (Icelandic Medicines Agency)

elocon smyrsli 0,1 %

n.v. organon* - mometasonum fúróat - smyrsli - 0,1 %

Elocon Krem 0,1 % 아이슬란드 - 아이슬란드어 - LYFJASTOFNUN (Icelandic Medicines Agency)

elocon krem 0,1 %

n.v. organon* - mometasonum fúróat - krem - 0,1 %

Elocon Húðlausn 0,1 % 아이슬란드 - 아이슬란드어 - LYFJASTOFNUN (Icelandic Medicines Agency)

elocon húðlausn 0,1 %

n.v. organon* - mometasonum fúróat - húðlausn - 0,1 %

Elidel Krem 1 % 아이슬란드 - 아이슬란드어 - LYFJASTOFNUN (Icelandic Medicines Agency)

elidel krem 1 %

viatris aps - pimecrolimusum inn - krem - 1 %

Nuvaxovid 유럽 연합 - 아이슬란드어 - EMA (European Medicines Agency)

nuvaxovid

novavax cz, a.s. - sars cov-2 (original) recombinant spike protein, sars-cov-2 (omicron xbb.1.5) recombinant spike protein - covid-19 virus infection - covid-19 vaccines - nuvaxovid is indicated for active immunisation to prevent covid-19 caused by sars-cov-2 in individuals 12 years of age and older. notkun þetta bóluefni ætti að vera í samræmi við opinbera tillögur. nuvaxovid xbb. 5 is indicated for active immunisation to prevent covid-19 caused by sars-cov-2 in individuals 12 years of age and older. notkun þetta bóluefni ætti að vera í samræmi við opinbera tillögur.